340 SW Boulevard, KCKS 66103
2002 S 51st St, KCKS 66103
913-722-3100

COVID-19

KEEPING YOU SAFE

       Our number one priority is keeping you, our patients, safe. This is why we are taking multiple precautions to ensure the safety of all patients and staff. Everyone who enters our clinics, including staff, patients and caregivers, will have thier temperature checked with a touchless infrared thermometer and will be required to wear a mask.
       To limit the number of individuals in the clinic, patients will be reminded that only necessary caregivers will be allowed to accompany them during their visit. Family members other than the patient or caregiver will be asked to return to their car. Time in the waiting room will be limited, to ensure proper social distancing, and masks will be provided for individuals as needed.

Know the Symptoms of COVID-19

Symptoms can range from mild to severe illness, and appear 2–14 days after you are exposed to the virus that causes COVID-19.

Seek medical care immediately if someone has Emergency Warning Signs of COVID-19:
•Trouble breathing
•Persistent pain or pressure in the chest
•New confusion
•Inability to wake or stay awake
•Bluish lips or face

What should I do if I suspect I have COVID-19 or may have been exposed?

1

Quarantine

Quarantine for 10 days, staying away from other people as much as possible.
    

2

Precautions

Wear a mask and monitor your symptoms.
     

3

Get Tested

Get a COVID-19 test approximately 5 -7 days after your exposure.
     

4

What if I Develop Symptoms?

If you have trouble breathing, extremely high temperature, or other acute symptoms, you should immediately call 911.

Can I Get Vaccinated At FHC?

       The State of Kansas has entered Phase 2 of its COVID-19 vaccine plan. Individuals aged 65+, those in eligible congregate settings, and all high-contact critical workers will now be prioritized for vaccination, in addition to anyone from Phase 1 who has not yet been vaccinated.
       Soon, FHC will begin to administer vaccines to existing patients who meet the eligibility requirements for Phase 2. We will contact eligible patients with more information once we receive the vaccine.